comparemela.com

Latest Breaking News On - Cardiff oncology daily - Page 4 : comparemela.com

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Drop in Short Interest

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Drop in Short Interest
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Denver
Colorado
United-states
California
Cardiff-oncology-inc
Denver-wealth-management-inc
Nasdaq
Cardiff-oncology
Get-free-report
Wealth-management
Street-group

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Large Drop in Short Interest

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the target of a large decrease in short interest during the month of July. As of July 15th, there was short interest totalling 492,900 shares, a decrease of 8.2% from the June 30th total of 537,000 shares. Based on an average daily trading volume, of 149,600 […]

California
United-states
Denver
Colorado
Denver-wealth-management-inc
Cardiff-oncology-company-profile
Cardiff-oncology-inc
Nasdaq
Cardiff-oncology
Get-free-report
Wealth-management

Cardiff Oncology (NASDAQ:CRDF) and Idorsia (OTCMKTS:IDRSF) Head-To-Head Survey

Cardiff Oncology (NASDAQ:CRDF – Get Free Report) and Idorsia (OTCMKTS:IDRSF – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Analyst Recommendations This is a breakdown of current recommendations […]

San-diego
California
United-states
Switzerland
Allschwil
Switzerland-general
Cardiff-oncology-inc
Janssen-biotech-inc
Trovagene-inc
Roche-inc
Neurocrine-biosciences-inc

HC Wainwright Lowers Cardiff Oncology (NASDAQ:CRDF) Price Target to $14.00

Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its price objective lowered by HC Wainwright from $15.00 to $14.00 in a research report sent to investors on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Cardiff Oncology’s Q2 2023 earnings at ($0.26) EPS, Q3 2023 earnings at ($0.27) EPS, Q4 2023 earnings at […]

Denver
Colorado
United-states
Denver-wealth-management-inc
Cardiff-oncology-inc
Cardiff-oncology
Get-rating
Wealth-management
Street-group
Two-sigma-investments
Polo-like-kinase

Cardiff Oncology (NASDAQ:CRDF) Price Target Cut to $14.00

Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its target price dropped by research analysts at HC Wainwright from $15.00 to $14.00 in a report issued on Tuesday, The Fly reports. Cardiff Oncology Stock Down 3.4 % Shares of Cardiff Oncology stock opened at $1.71 on Tuesday. Cardiff Oncology has a twelve month low of $1.13 […]

Denver
Colorado
United-states
Denver-wealth-management-inc
Cardiff-oncology-inc
Cardiff-oncology
Get-rating
Oncology-stock-down
Wealth-management
Street-group
Sigma-investments

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.